Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Vehicle Controlled, Double Blind, Parallel Group, Multi Center PhaseIII Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

NCT01878461 is registered in ClinicalTrials.gov with Maruho North America Inc. as lead sponsor.

NCT NCT01878461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01878461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Vehicle Controlled, Double Blind, Parallel Group, Multi Center PhaseIII Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
Lead sponsor
Maruho North America Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2013
Completion date
May 31, 2015
Enrollment
542 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis